QuickView for ADORA2B;jsessionid=01DC8EB23C428BB3B92744CA02AC630F;jsessionid=51F5F0059393C95F8F4FD5FA5A29ED11;jsessionid=AE35022AB1129D94B3B8A78B18AEB8F5;jsessionid=32B1F7462C791CBED1CDA2A55545363F;jsessionid=AD366E35DCBF2CBFB7461CC0A7FC3EDF (gene)

1. The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.
2. Irreversible Antagonists for the Adenosine A2B Receptor.
3. A patent review of adenosine A2B receptor antagonists (2016-present).
4. Dexmedetomidine alleviates pulmonary fibrosis through the ADORA2B-Mediated MAPK signaling pathway.
5. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Can…

There were no clinical trials for ADORA2B;jsessionid=01DC8EB23C428BB3B92744CA02AC630F;jsessionid=51F5F0059393C95F8F4FD5FA5A29ED11;jsessionid=AE35022AB1129D94B3B8A78B18AEB8F5;jsessionid=32B1F7462C791CBED1CDA2A55545363F;jsessionid=AD366E35DCBF2CBFB7461CC0A7FC3EDF